I probably contributed to a lot of the January 2nd Hype after reading about the EPA and the Christmas letter. Once they obtained EPA and they had one of the Hospitals that Caponi works with, it "SEEMED" like a NO BRAINER that they would have pre-arranged the Trials as soon as the New Year started.
I apologize to everyone who followed my line of reasoning. I believed it for myself because I would not waste one minute once I had EPA approval.
I still do not understand the delay. I keep hoping that they already did the Trials and are waiting for a Back order of manufacturing to CO-Announce a larger order. But that is probably more wishful thinking.
The announcement refers to "latter half of 2017."
******************
Given the current level of interest we are seeing in AsepticSure, both in the United States and from other regions, we truly believe that we are now entering a year of expanded product recognition and acceptance. This is expected to lead to profitability, sustainable revenues and encouraging growth curves as we progress through the latter half of 2017.
*******************
Growth curves is very different from a US Trial, or from making a single sale. Growth is growth, a SINGLE sale is a single sale.
Market Data 
Markets 
